A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...
News-Medical.Net on MSN
Exa-cel shows complete success in early pediatric trials for sickle cell disease and beta-thalassemia
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
That observation was prompted by a visit to the walk-in storage cooler inside the Blood Bank in UAB Hospital. If you are ...
ISC Biology Specimen Paper 2026 Class 12 helps students understand exam pattern, important topics, and marking scheme for the ...
In a time when conversations around inclusion often remain at the surface, a young Cell Biology and Genetics student from the ...
1don MSN
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...
The new clinic aims to expand access to specialized care for a community disproportionately affected by sickle cell disease.
News-Medical.Net on MSN
New evidence shows hematopoietic cell transplantation offers durable relief for sickle cell disease
Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...
Exagamglogene autotemcel helped children with beta thalassemia achieve transfusion independence and prevented vaso-occlusive ...
Scientific American hosted an event at Morehouse School of Medicine to highlight medical advances in treating sickle cell ...
Nagpur: India is entering a transformative phase where genetic science will increasingly steer how doctors diagnose, prevent, ...
Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Citi Annual Global Healthcare Conference 2025 December 2, 2025 2:30 PM ESTCompany ParticipantsSteven Harr - President, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results